US · LFVN · PACKAGED FOODS
LifeVantage Corporation (LFVN) intrinsic value and stock valuation
$4.15as of 2026-11-21 · Mkt cap 85.28M
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
LifeVantage Corporation DCF and intrinsic value
InvestorsCraft values LFVN with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from LFVN’s statements →
LifeVantage Corporation Graham Number
Graham Number: $7.13d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Chegg, Inc. (CHGG) $0.48
- Ispire Technology Inc. (ISPR) $1.23
- Bridgford Foods Corporation (BRID) $5.01
- Wing Yip Food Holdings Group Limited American Depositary Shares (WYHG) $2.62
- The Hain Celestial Group, Inc. (HAIN) $0.10
- Sunlands Technology Group (STG) $1.59
- Borealis Foods Inc. (BRLS) $0.70
- Agape ATP Corporation (ATPC) $1.16
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $228.5M | $200.2M | $213.4M | $206.4M | $220.2M |
| Operating income | $12.2M | $4.33M | $4.26M | $7.58M | $17.6M |
| Net income | $9.8M | $2.94M | $2.54M | $3.12M | $12.9M |
| EPSd | $754.4K | $226.3K | $202.1K | $238.7K | $903.3K |
| Operating cash flow | $11.9M | $12.2M | $6.83M | $7.96M | $7.96M |
| Capital expenditure | -$-1.37M | -$-2.25M | -$-3.07M | -$-1.53M | -$-1.53M |
| Free cash flow | $10.5M | $9.95M | $3.76M | $6.43M | $6.43M |
| Total assets | $72M | $60.3M | $66.1M | $70.7M | $78.7M |
| Total debt | $11.7M | $13.6M | $13.1M | $15.8M | $18.2M |
| Net debt | -$-8.52M | -$-3.27M | -$-8.52M | -$-4.43M | -$-4.99M |
| Total equity | $34.6M | $26M | $34.7M | $31.5M | $36.8M |
| Cash and short-term investments | $20.2M | $16.9M | $21.6M | $20.2M | $23.2M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $228.5M | $200.2M | $213.4M | $206.4M | $220.2M |
| Cost of revenue | $44.9M | $41.4M | $43.4M | $38.1M | $38.2M |
| Gross profit | $183.7M | $158.7M | $170M | $168.3M | $182M |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $700K |
| Selling, general and administrative expenses | $69.2M | $68.5M | $71.1M | $63.4M | $164.4M |
| Other expenses | $102.3M | $85.9M | $94.7M | $97.3M | -$-700K |
| Operating expenses | $171.5M | $154.4M | $165.8M | $160.7M | $164.4M |
| Cost and expenses | $216.3M | $195.8M | $209.1M | $198.8M | $202.6M |
| Interest income | $430K | $430K | $200K | $0.00 | $0.00 |
| Interest expense | $0.00 | $0.00 | $0.00 | $10K | $20K |
| Depreciation and amortization | $3.16M | $3.58M | $3.58M | $3.26M | $3.46M |
| Ebitda | $15.4M | $7.93M | $7.58M | $7.96M | $20.7M |
| Operating income | $12.2M | $4.33M | $4.26M | $7.58M | $17.6M |
| Total other income/expenses, net | $40K | $20K | -$-260K | -$-2.88M | -$-380K |
| Income before tax | $12.2M | $4.35M | $4M | $4.69M | $17.2M |
| Income tax expense | $2.44M | $1.41M | $1.46M | $1.57M | $4.34M |
| Net income | $9.8M | $2.94M | $2.54M | $3.12M | $12.9M |
| Weighted average shares outstanding | $12.3M | $12.5M | $12.6M | $12.9M | $14.1M |
| Weighted average diluted shares outstanding | $13M | $13M | $12.6M | $13.1M | $14.3M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $20.2M | $16.9M | $21.6M | $20.2M | $23.2M |
| Net receivables | $3.93M | $3.26M | $1.85M | $5.09M | $3.96M |
| Inventory | $20.7M | $15.1M | $16.1M | $16.5M | $16.1M |
| Total current assets | $50.9M | $37.7M | $44.3M | $47M | $48.1M |
| Property, plant and equipment, net | $14.3M | $17.4M | $17.8M | $20.5M | $24.8M |
| Goodwill and intangible assets | $240K | $320K | $460K | $590K | $720K |
| Long-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $2.21M |
| Total non-current assets | $21.1M | $22.7M | $21.8M | $23.8M | $30.7M |
| Total assets | $72M | $60.3M | $66.1M | $70.7M | $78.7M |
| Accounts payable | $5.06M | $6.29M | $4.22M | $7.92M | $7.59M |
| Short-term debt | $1.87M | $1.81M | $1.52M | $2.6M | $2.15M |
| Deferred revenue | $710K | $860K | $830K | $80K | $320K |
| Total current liabilities | $27.2M | $22.3M | $19.6M | $25.7M | $25.2M |
| Long-term debt | $9.81M | $11.8M | $11.6M | $13.2M | $16M |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $10.1M | $12M | $11.9M | $13.5M | $16.7M |
| Capital lease obligations | $11.7M | $13.6M | $13.1M | $15.8M | $18.2M |
| Total liabilities | $37.3M | $34.3M | $31.5M | $39.2M | $41.9M |
| Common stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Retained earnings | -$-104.15M | -$-108.74M | -$-98.31M | -$-98.44M | -$-92.35M |
| Accumulated other comprehensive income (loss) | -$-1.18M | -$-1.92M | -$-1.36M | -$-1.12M | $100K |
| Total equity | $34.6M | $26M | $34.7M | $31.5M | $36.8M |
| Total investments | $0.00 | $0.00 | $0.00 | $0.00 | $2.21M |
| Total debt | $11.7M | $13.6M | $13.1M | $15.8M | $18.2M |
| Net debt | -$-8.52M | -$-3.27M | -$-8.52M | -$-4.43M | -$-4.99M |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $9.8M | $2.94M | $2.54M | $3.12M | $3.12M |
| Depreciation and amortization | $3.16M | $3.58M | $3.58M | $3.26M | $3.26M |
| Stock-based compensation | $5.7M | $3.28M | $3.19M | $1.77M | $1.77M |
| Change in working capital | -$-6.55M | $2.38M | -$-2.56M | -$-4.1M | -$-4.1M |
| Accounts receivable | -$-560K | -$-1.5M | $3.07M | -$-1.33M | -$-1.33M |
| Inventory | -$-5.22M | $660K | $60K | -$-1.19M | -$-1.19M |
| Accounts payable | -$-1.29M | $2.3M | -$-3.98M | $820K | $820K |
| Net cash provided by operating activities | $11.9M | $12.2M | $6.83M | $7.96M | $7.96M |
| Investments in property, plant and equipment | -$-1.37M | -$-2.25M | -$-3.07M | -$-1.53M | -$-1.53M |
| Acquisitions, net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for investing activities | -$-1.37M | -$-2.25M | -$-3.06M | -$-1.53M | -$-1.53M |
| Common stock issued | $280K | $270K | $250K | $510K | $0.00 |
| Common stock repurchased | -$-3.15M | -$-7.65M | -$-820K | -$-9.08M | -$-9.08M |
| Dividends paid | -$-2.07M | -$-6.94M | -$-1.59M | -$-380K | -$-380K |
| Net cash used for financing activities | -$-7.6M | -$-14.42M | -$-2.36M | -$-8.95M | -$-8.95M |
| Net change in cash | $3.31M | -$-4.72M | $1.42M | -$-2.98M | -$-2.98M |
| Cash at end of period | $20.2M | $16.9M | $21.6M | $20.2M | $20.2M |
| Operating cash flow | $11.9M | $12.2M | $6.83M | $7.96M | $7.96M |
| Capital expenditure | -$-1.37M | -$-2.25M | -$-3.07M | -$-1.53M | -$-1.53M |
| Free cash flow | $10.5M | $9.95M | $3.76M | $6.43M | $6.43M |
Line items
Line items
Line items
About LifeVantage Corporation
LifeVantage Corporation (LFVN) specializes in the development, manufacture, and distribution of a diverse portfolio of health, wellness, and personal care products. Its offerings encompass nutrigenomic activators (designed to influence genetic expression), a broad array of dietary supplements, cognitive enhancers (nootropics), gut health support (pre- and pro-biotics), weight management solutions, and various personal care items spanning skin care, hair care, bath and body, and targeted relief. The company's product lineup features well-known brands such as Protandim, a series of scientifically validated dietary supplements. Specific examples include LifeVantage Omega+, a blend of DHA/EPA Omega-3s, Omega-7s, and Vitamin D3; LifeVantage ProBio, designed for digestive wellness; the PhysIQ brand for weight management; Petandim, tailored to reduce oxidative stress in dogs; and Axio energy drink mixes. Under the TrueScience brand, LifeVantage also provides anti-aging skincare (e.g., facial cleansers, perfecting lotions, eye serums, creams), hair care solutions (e.g., invigorating shampoos, nourishing conditioners, scalp serums), and an assortment of bath and body products (e.g., body lotion, wash, butter, deodorant) and targeted relief items (e.g., soothing balm, body rub). Distribution occurs through both its proprietary website and an extensive network of independent distributors. LifeVantage maintains a significant international presence, with operations spanning numerous global territories including the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. The corporation's headquarters are situated in Lehi, Utah.
- CEO
- Michael A. Beindorff
- Employees
- 238
- Beta
- 0.76
Explore
Frequently asked questions
What is the intrinsic value of LifeVantage Corporation (LFVN)?
LifeVantage Corporation (LFVN) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is LFVN undervalued?
LFVN trades at a price of $4.15 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.